Run by Former Genentech Employees, Bay Area's Denali Seeks $100M IPO Post author:Sam Post published:November 13, 2017 Post category:BioPharma Denali plans to make a $100M IPO under the symbol DNLI. Source: BioSpace You Might Also Like Syros Pharma To Present Biomarker Data From Ongoing Phase 2 Clinical Trial Of SY-1425 At Conference On AML September 28, 2017 <b>ADC Bio</b> To Invest $11 Million On Bioconjugation Facility September 26, 2017 Leap Therapeutics Reports Second Quarter 2017 Financial Results August 10, 2017
Syros Pharma To Present Biomarker Data From Ongoing Phase 2 Clinical Trial Of SY-1425 At Conference On AML September 28, 2017
